We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current AMPLI market cap is 143.96M. The company's latest EPS is EUR 0.8178 and P/E is 3.67.
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 105.28M | 89.39M | 96.53M | 109.43M | 180.95M |
| Operating Income | 4.92M | 1.89M | 1.55M | 4.89M | 56.3M |
| Net Income | -8.99M | -14.2M | -14.1M | -4.39M | 39.25M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 279.92M | 275.21M | 269.07M | 259.46M | 266.02M |
| Total Liabilities | 194.43M | 204.29M | 212.21M | 206.89M | 170.2M |
| Total Equity | 85.5M | 70.91M | 56.87M | 52.57M | 95.81M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 8.24M | 12.38M | 2.34M | 7.98M | 8.1M |
| Investing | -13.78M | -9.58M | -9.16M | -12.41M | 45.54M |
| Financing | -4.31M | 14.76M | 736k | -5.41M | -37.43M |
| Market Cap | 143.96M |
| Price to Earnings Ratio | 3.67 |
| Price to Sales Ratio | 0.8 |
| Price to Cash Ratio | 3.87 |
| Price to Book Ratio | 1.5 |
| Dividend Yield | - |
| Shares Outstanding | 47.99M |
| Average Volume (1 week) | 4.84k |
| Average Volume (1 Month) | 5.19k |
| 52 Week Change | -11.76% |
| 52 Week High | 3.68 |
| 52 Week Low | 2.88 |
| Spread (Intraday) | 0.04 (1.32%) |
| Company Name | Amplitude Surgical |
| Address |
11 cours jacques offenbach valence, drome 26000 |
| Website | https://www.amplitude-ortho.com |
| Industry | gen med & surgical hospitals (8062) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
